This inventor holds 36 USPTO granted patents and 3 published patent applications and 11 EPO patents, primarily in Biomedical Imaging. Top assignees: Canon Kabushiki Kaisha, Kabushiki Kaisha Toshiba, Mitsubishi Pencil Company, Limited. Active years: 1994-2025.
Location History:
- Meguro-ku, JP (2008)
- Tachikawa, JP (2011)
- Chofu, JP (2009 - 2012)
- Yokohama, JP (2012 - 2019)
- Brookline, MA (US) (2016 - 2021)
- Tokyo, JP (1994 - 2023)
Company Filing History:
30 out of 92,842 
2 out of 53,240 
2 out of 392 
Years Active: 1994-2025
Areas of Expertise:
Title: Innovations by Kohei Watanabe: A Pioneer in Cancer Research
Introduction:
Kohei Watanabe, hailing from Yokohama, Japan, is a prominent inventor with 31 patents to his name. His work significantly contributes to the fields of fluorescence imaging and cancer research, showcasing his innovative spirit and commitment to advancing medical technologies.
Latest Patents:
Watanabe's recent advancements include a pioneering **Fluorescence Imaging Apparatus** that enhances the accuracy of fluorescence calibration. This method involves directing excitation light onto an object through an optical probe, detecting resultant fluorescence light, and acquiring structural data. This data allows for the calculation of the object’s optical attenuation properties, leading to refined fluorescence intensity calibration.
Additionally, he has made strides in oncology with his patents related to methods of detecting and screening cancer stem cells. Notably, his invention provides a novel cancer cell inhibitory drug, particularly targeting cancer stem cells, employing compounds defined by a specific general formula as active ingredients.
Career Highlights:
Throughout his career, Kohei Watanabe has made substantial contributions while working at well-known companies, including Canon and Medgel Corporation. His innovative research and patent filings reflect his keen ability to address complex medical challenges through technology.
Collaborations:
Watanabe has collaborated with esteemed colleagues such as Takeshi Miyazaki and Tsuyoshi Nomoto. Together, their combined expertise enhances the potential for groundbreaking developments in medical innovations and technologies, particularly in the fight against cancer.
Conclusion:
Kohei Watanabe continues to be a significant figure in the landscape of innovation, especially in the realms of fluorescence imaging and cancer treatment. His portfolio of patents and collaborations underscores his dedication to creating meaningful solutions that push the boundaries of current medical research. As he progresses in his career, the scientific community eagerly anticipates his future contributions.